Lauren Santye, Assistant Editor

Study links anti-tumor immunity to islet autoimmunity.

Top news of the day from across the health care landscape.

The risk of a second cancer remained high even 30 years after treatment.

Progression-free survival with IMMU-132 increases from an average of 3.5 months to 16.6 months in patients with breast cancer.

Round 2 of study finds a reduction in start time of antiretroviral therapy for HIV treatment.

Test delivers the results of a multiple sclerosis diagnosis in as few as 7 days.

Top news of the day from across the health care landscape.

Preliminary trial finds moderate-intensity exercise does not increase adverse events in this patient population.

Americans admitted to the hospital for heart failure have a 6% higher risk of dying than patients admitted in the spring.

Treatments have only increased 10% in hospitals nationwide over the past decade.

A self-expanding transcatheter aortic valve replacement (TAVR) procedure was just as effective as surgery in intermediate risk patients.

The PCSK9 inhibitor dramatically reduces high cholesterol and cuts the risk of heart attack and stroke.

The Blueprint for Transparency at the FDA provides 18 recommendations for the release of regulatory information and data.

Study is the first to examine the function of SP140 protein in inflammatory diseases.

Insulin could become a new therapeutic option for HIV-associated neurocognitive disorders.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses methods pharmacists can employ to maintain adherence.

Top news of the day from across the health care landscape.

A combination drug regimen may be the answer to treating acute myeloid leukemia.

Small case report found an association between the Zika virus and cardiovascular complications.

FOURIER trial meets its primary composite endpoint reducing cardiovascular risk factors.

Mylan gains global licenses for its biosimilar to trastuzumab (Herceptin).

Senescent cells communication via integrin beta 3 expression.

Daniel P. Kus, BS Pharm, RPh, vice president, Pharmacy Advantage, discusses key quality measures that define successful specialty pharmacies.

ATR mutations increase skin cancer tumor growth by modulating the tumor microenvironment.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Improvements in breast cancer patient quality of life and mortality seen over last 30 years.

Heart failure higher among RA patients independent of their risk for ischemic heart disease.

Hypertension can cause cardiovascular risk factors in patients with HIV.

A majority of patients experienced the same level of skin clearing as initial treatment with Cosentyx.